Picard Medical (PMI) Stock Analysis
AMEXHealthcareMedical - Devices
What Picard Medical does
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.
Key metrics
ETFs linked to PMI
Broad-market and Healthcare sector ETFs an investor holding Picard Medical is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how PMI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze PMI in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Picard Medical?
- Picard Medical trades under the ticker PMI on AMEX.
- Which exchange is PMI listed on?
- PMI is listed on AMEX.
- What sector does Picard Medical operate in?
- Picard Medical is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze PMI in a portfolio?
- PortView shows PMI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.